Herpes Simplex Keratitis Treatment Market Forecast Highlights Expanding Therapeutic Opportunities
The global herpes simplex keratitis (HSK) treatment market is entering a period of robust expansion, backed by rising disease prevalence, increasing awareness programs, and continuous pharmaceutical innovation. According to recent industry assessments, the market is projected to grow from US$4.5 billion in 2023 to US$8.3 billion by 2030, advancing at an impressive CAGR of 9% during the forecast period. As manufacturers invest in advanced antiviral formulations and ophthalmic drug delivery technologies, healthcare providers worldwide are strengthening their therapeutic approaches to manage one of the leading causes of infectious blindness.